Actively Recruiting
Study Comparing Sensitivity of Different Thromboplastin Reagents on Blood Clotting Tests in Patients with Extrinsic Pathway Factor Deficiency or Liver-related Coagulopathy
Led by University Hospital, Strasbourg, France · Updated on 2025-08-08
100
Participants Needed
1
Research Sites
50 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the sensitivity of various thromboplastin reagents used in prothrombin time and factor II, V, VII, and X assays. This study focuses on two patient groups those with isolated extrinsic pathway factor deficiencies either acquired or congenital and those with hepatocellular insufficiency linked to coagulopathy that varies with liver impairment severity. The goal is to improve understanding of how different thromboplastin reagents perform in detecting these coagulopathies and to assist laboratories in selecting the most suitable reagent. The study observes plasma samples from patients with extrinsic pathway factor deficiencies or liver-related coagulopathy. Different thromboplastin reagents are compared by analyzing prothrombin time results and factor assays using statistical methods such as regression lines and Bland-Altman representations. This observational approach does not involve administering treatments but focuses on laboratory evaluation of blood samples collected during routine care. Participants will have their plasma samples anonymized and analyzed to measure prothrombin time and factor activity using various reagents. The primary outcome is the comparison of reagent sensitivity over 18 months. This includes assessing how well the prothrombin time corresponds to factor activity levels for each reagent. No experimental treatments are given, and the study relies on existing samples from routine testing, ensuring participant safety and confidentiality throughout the process.
CONDITIONS
Brief Title
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.
Research Team
J
Jordan Laurent WIMMER
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here